Missouri HB3117 limits cost-sharing for prescription insulin drugs to $30 per 30-day supply.

Missouri HB3117 enacts provisions to limit cost-sharing for prescription insulin drugs to $30 per 30-day supply for enrollees. The bill defines "prescription insulin drug" as a drug containing insulin and another entity, excluding those administered intravenously. It prohibits health benefit plans from imposing higher cost-sharing on enrollees for these drugs. Rebates received by health carriers for these drugs must be used to reduce the enrollee's cost-sharing, though the exact method of calculation is flexible.

Missouri HB3117 limits cost-sharing for prescription insulin drugs to $30 per 30-day supply.

Missouri HB3117 enacts provisions to limit cost-sharing for prescription insulin drugs to $30 per 30-day supply for enrollees. The bill defines "prescription insulin drug" as a drug containing insulin and another entity, excluding those administered intravenously. It prohibits health benefit plans from imposing higher cost-sharing on enrollees for these drugs. Rebates received by health carriers for these drugs must be used to reduce the enrollee's cost-sharing, though the exact method of calculation is flexible.